Similar Search Results

Can a disease-based price index improve the estimation of the Medical Consumer Price Index?

Song, Xue; Marder, William D.; Houchens, Robert L.; … - In: Price index concepts and measurement : [revised …, (pp. 329-368). 2009

Persistent link: https://www.econbiz.de/10003943338

Pricing and reimbursement in US pharmaceutical markets

Berndt, Ernst R.; Newhouse, Joseph P. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important...

Persistent link: https://www.econbiz.de/10008656716

Impacts of patent expiry and regulatory policies on daily cost of pharmaceutical treatments : OECD countries, 2004 - 2010

Berndt, Ernst R.; Dubois, Pierre - 2012

Persistent link: https://www.econbiz.de/10009578828

The effect of FDA advisories on branded pharmaceutical firms' valuations and promotion efforts

Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - 2011

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of...

Persistent link: https://www.econbiz.de/10009374023